MSKai Releases Innovative Lumbar Spine MRI Segmentation and Measurement Artificial Intelligence Technology

MSKai, a developer of Artificial Intelligence-based radiological assist software for the musculoskeletal system, announces the release of the company’s Lumbar Spine MRI segmentation and measurement algorithm in conjunction with submission of a United States Provisional Patent application for “Systems and Methods for Improving Patient Outcomes for Musculoskeletal Care.”

“Artificial Intelligence is rapidly integrating into healthcare,” said Adam Bruggeman, MD, chief medical officer of MSKai. “The ability to accurately and consistently identify and measure spine anatomy will lead to further efficiencies for patients and providers in the practice of spine surgery.”

The current software is a radiological assist system for the evaluation of Lumbar Spine pathologies providing spine care practicitioners the ability to identify, measure, and classify spinal anatomy and pathologies from a quantitative and qualitative standpoint within seconds. The distinctive machine learning algorithm provides anatomical segmentation, anatomical measurement, pathology classification, and range threshold alerts.

The initial validation for MSKai’s Lumbar Spine MRI segmentation and measurement is derived from 413 patient MRI studies. When comparing ground truth data from six independent medical and biomechanical professionals, the measurement accuracy and segmentation accuracy range from 76% to 90%, depending on the focus. The current segmentation and measurement algorithm continues to improve with consistency and sets the framework for the evolution of machine learning-based radiological assist systems being integrated into clinical practice.

SourceMSKai

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”